Published in J Alzheimers Dis on January 01, 2013
Protein phosphorylation in neurodegeneration: friend or foe? Front Mol Neurosci (2014) 1.15
Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3β, neurotrophin-3 and CREB signaling. PLoS One (2013) 0.97
Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells. Drug Des Devel Ther (2015) 0.90
Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth. Oncogene (2014) 0.88
Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis. Biochim Biophys Acta (2015) 0.86
A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease. PLoS One (2014) 0.85
Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage. Biochim Biophys Acta (2013) 0.84
GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. Cell Death Differ (2014) 0.82
Nebula/DSCR1 upregulation delays neurodegeneration and protects against APP-induced axonal transport defects by restoring calcineurin and GSK-3β signaling. PLoS Genet (2013) 0.81
esyN: network building, sharing and publishing. PLoS One (2014) 0.81
Treadmill exercise decreases incidence of Alzheimer's disease by suppressing glycogen synthase kinase-3β expression in streptozotocin-induced diabetic rats. J Exerc Rehabil (2015) 0.80
Regulation of mineral metabolism by lithium. Pflugers Arch (2013) 0.79
Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells. Drug Des Devel Ther (2014) 0.79
Toll-like receptor 4-mediated signaling participates in apoptosis of hippocampal neurons. Neural Regen Res (2013) 0.78
Searching for novel Cdk5 substrates in brain by comparative phosphoproteomics of wild type and Cdk5-/- mice. PLoS One (2014) 0.78
The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation. J Biol Chem (2014) 0.77
Acute Ethanol Inhibition of γ Oscillations Is Mediated by Akt and GSK3β. Front Cell Neurosci (2016) 0.77
The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease. Oxid Med Cell Longev (2015) 0.77
Silencing [Formula: see text] Rescues Tau Pathologies and Memory Deficits through Rescuing PP2A and Inhibiting GSK-3β Signaling in Human Tau Transgenic Mice. Front Aging Neurosci (2014) 0.77
Phosphokinase antibody arrays on dendron-coated surface. PLoS One (2014) 0.76
GSK3β Interactions with Amyloid Genes: An Autopsy Verification and Extension. Neurotox Res (2015) 0.76
In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology. Acta Neuropathol Commun (2013) 0.76
Hyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble. PLoS One (2015) 0.76
Early glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway. Eur J Neurosci (2016) 0.75
Modeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns. Stem Cells Int (2016) 0.75
Diversity-Oriented Synthesis as a Strategy for Fragment Evolution against GSK3β. ACS Med Chem Lett (2016) 0.75
Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction. J Mol Psychiatry (2015) 0.75
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein. Aging Cell (2016) 0.75
The combination effects of licl and the active leflunomide metabolite, A771726, on viral-induced interleukin 6 production and EV-A71 replication. PLoS One (2014) 0.75
Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice. Front Mol Neurosci (2017) 0.75
Glycogen synthase kinase-3β regulates fractalkine production by altering its trafficking from Golgi to plasma membrane: implications for Alzheimer's disease. Cell Mol Life Sci (2016) 0.75
Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal. Drug Discov Today (2016) 0.75
Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model. Brain (2017) 0.75
Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies. BMC Neurosci (2015) 0.75
In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains. Sci Rep (2017) 0.75
The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells. Front Mol Neurosci (2017) 0.75
Ovariectomy increases the age-induced hyperphosphorylation of Tau at hippocampal CA1. Cogn Process (2016) 0.75
Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J Biol Chem (2003) 2.65
Role of tau protein in both physiological and pathological conditions. Physiol Rev (2004) 2.44
Tau--an inhibitor of deacetylase HDAC6 function. J Neurochem (2009) 1.27
MAP1B regulates axonal development by modulating Rho-GTPase Rac1 activity. Mol Biol Cell (2010) 1.17
Microtubule-associated protein 1B function during normal development, regeneration, and pathological conditions in the nervous system. J Neurobiol (2004) 1.09
High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J Biol Chem (2001) 1.07
Oxidative imbalance in Alzheimer's disease. Mol Neurobiol (2005) 1.05
CHOP regulates the p53-MDM2 axis and is required for neuronal survival after seizures. Brain (2013) 1.02
Microtubule-associated protein 1B is involved in the initial stages of axonogenesis in peripheral nervous system cultured neurons. Brain Res (2002) 1.00
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment. Proc Natl Acad Sci U S A (2009) 0.98
Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments. J Neurosci Res (2008) 0.98
Immunotherapy for neurological diseases. Clin Immunol (2008) 0.97
Characteristics and consequences of muscarinic receptor activation by tau protein. Eur Neuropsychopharmacol (2009) 0.92
DNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease. Brain (2013) 0.91
Tau phosphorylation in hippocampus results in toxic gain-of-function. Biochem Soc Trans (2010) 0.87
Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2. J Neurosci (2006) 0.87
Role for the alpha-helix in aberrant protein aggregation. Biochemistry (2005) 0.85
Blocking Effects of Human Tau on Squid Giant Synapse Transmission and Its Prevention by T-817 MA. Front Synaptic Neurosci (2011) 0.85
Role of tau protein on neocortical and hippocampal oscillatory patterns. Hippocampus (2010) 0.85
BDNF production by olfactory ensheathing cells contributes to axonal regeneration of cultured adult CNS neurons. Neurochem Int (2006) 0.83
Beta-amyloid impairs reelin signaling. PLoS One (2013) 0.82
MAP1B binds to the NMDA receptor subunit NR3A and affects NR3A protein concentrations. Neurosci Lett (2010) 0.82
Tau protein role in sleep-wake cycle. J Alzheimers Dis (2010) 0.81
α-Synuclein levels affect autophagosome numbers in vivo and modulate Huntington disease pathology. Autophagy (2012) 0.81
Impaired ATF6α processing, decreased Rheb and neuronal cell cycle re-entry in Huntington's disease. Neurobiol Dis (2010) 0.81
Differential gene expression analysis of human entorhinal cortex support a possible role of some extracellular matrix proteins in the onset of Alzheimer disease. Neurosci Lett (2009) 0.79
Autoinhibition of TBCB regulates EB1-mediated microtubule dynamics. Cell Mol Life Sci (2012) 0.79
Tau aggregation followed by atomic force microscopy and surface plasmon resonance, and single molecule tau-tau interaction probed by atomic force spectroscopy. J Alzheimers Dis (2009) 0.78
Looking for novel functions of tau. Biochem Soc Trans (2012) 0.77
Treating the lesions, not the disease. Am J Pathol (2007) 0.77
Hyperphosphorylated tau aggregates in the cortex and hippocampus of transgenic mice with mutant human FTDP-17 Tau and lacking the PARK2 gene. Acta Neuropathol (2008) 0.76
Memory and exploratory impairment in mice that lack the Park-2 gene and that over-express the human FTDP-17 mutant Tau. Behav Brain Res (2008) 0.76
Highly efficient and specific gene transfer to Purkinje cells in vivo using a herpes simplex virus I amplicon. Hum Gene Ther (2002) 0.76
Neuronal models for studying tau pathology. Int J Alzheimers Dis (2010) 0.75
A proteomic approach for the involvement of the GAPDH in Alzheimer disease in the blood of Moroccan FAD cases. J Mol Neurosci (2014) 0.75
Centro de Biologia Molecular "Severo Ochoa": a center for basic research into Alzheimer's disease. J Alzheimers Dis (2010) 0.75
Park2-null/tau transgenic mice reveal a functional relationship between parkin and tau. J Alzheimers Dis (2008) 0.75